WestEnd Advisors’s Bio-Techne TECH Stock Holding History

WestEnd Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$495	Hold	7	–	–	﹤0.01%	341
2026 Q1	$366	Hold	7	–	–	﹤0.01%	333
2025 Q4	$412	Buy	7 +3	+75%	+$182	﹤0.01%	325
2025 Q3	$223	Sell	4 -2	-33%	-$107	﹤0.01%	374
2025 Q2	$309	Hold	6	–	–	﹤0.01%	323
2025 Q1	$352	Buy	6 +4	+200%	+$271	﹤0.01%	305
2024 Q4	$144	Hold	2	–	–	﹤0.01%	292
2024 Q3	$160	Hold	2	–	–	﹤0.01%	313
2024 Q2	$143	Sell	2 -1	-33%	-$74	﹤0.01%	293
2024 Q1	$211	Buy	3 +1	+50%	+$72	﹤0.01%	244
2023 Q4	$154	Hold	2	–	–	﹤0.01%	253
2023 Q3	$136	Buy	+2	New	+$158	﹤0.01%	253
2023 Q1	–	Sell	-4	Closed	-$308	–	254
2022 Q4	$332	Hold	4	–	–	﹤0.01%	181
2022 Q3	$0	Buy	+4	New	+$346	﹤0.01%	311

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

WestEnd Advisors's TECH Position: Q2 2026 in Review

WestEnd Advisors held its Bio-Techne (TECH) position steady in Q2 2026 at 7 shares worth $495. The position accounts for ﹤0.01% of the portfolio, ranked #341.

WestEnd Advisors first reported a position in TECH in Q3 2022 and has held it in 14 quarters since. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

WestEnd Advisors held 7 shares of Bio-Techne worth $495 as of Q2 2026.
WestEnd Advisors left its Bio-Techne share count unchanged in Q2 2026.
Bio-Techne made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #341 holding.
WestEnd Advisors first reported a position in Bio-Techne in Q3 2022 and has held it in 14 quarters since.
595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.